Medscape weighs GLP-1 therapy limits in obstructive sleep apnea
The review describes promise for GLP-1 drugs in OSA while flagging boundaries to their clinical benefit.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 05:29 ETSource: Medscape
The wire
- 01Medscape published a clinical review on GLP-1 therapy for obstructive sleep apnea.
- 02OSA has become a growing indication area for GLP-1 receptor agonists tied to weight reduction.
- 03The piece's specific limitations and data sources were not detailed in the excerpt.
From the source
Read at news.google.comGLP-1 Therapy and OSA: Promise, But Limits